Inhibitory Effects of Phenolic Alkaloids of Menispermum Dauricum on Gastric Cancer in Vivo

  • Zhang, Hong-Feng (Department of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital) ;
  • Wu, Di (Department of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital) ;
  • Du, Jian-Kuo (Department of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital) ;
  • Zhang, Yan (Department of Pharmacology, School Basic Medical Sciences of Heilongjiang University of Chinese Medicine) ;
  • Su, Yun-Ming (Department of Pharmacology, School Basic Medical Sciences of Heilongjiang University of Chinese Medicine)
  • 발행 : 2015.01.22


The present study was conducted to investigate effects and mechanisms of action of phenolic alkaloids of Menispermum dauricum (PAMD) on gastric cancer in vivo. In vitro, cell apoptosis of human gastric cancer cell line SGC-7901 was observed using fluorescence staining. In vivo, a mice model was constructed to observe tumor growth with different doses. Cell apoptosis was examined using flow cytometry and K-RAS protein expression using Western blotting. The mRNA expression of P53, BCL-2, BAX, CASPASE-3, K-RAS was examined by real-time PCR. PAMD significantly suppressed tumor growth in the xenograft model of gastric cancer in a dose-dependent manner (p<0.01). Functionally, PAMD promoted cell apoptosis of the SGC-7901 cells and significantly increased the rate of cell apoptosis of gastric tumor cells (p<0.05). Mechanically, PAMD inhibited the expression of oncogenic K-RAS both at the mRNA and protein levels. In addition, PAMD affected the mRNA expression of the cell apoptosis-related genes (P53, BCL-2, BAX, CASPASE-3). PAMD could suppress gastric tumor growth in vivo, possibly through inhibiting oncogenic K-RAS, and induce cell apoptosis possibly by targeting the cell apoptosis-related genes of P53, BCL-2, BAX, CASPASE-3.


  1. Bian YJ, Li H, Su YM (2010). Effects of PAMD on the expression of K-ras mRNA of mice-transplanted pancreatic cancer BXPC-3 cells. Inform Tradit Chinese Medicine, 2, 38.
  2. Bickenbach KA, Denton B, Gonen M, et al (2013). Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer. Ann Surg Oncol, 20, 780-7.
  3. Chen H, Pan Y, Cheng ZY, et al (2013). Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer. Asian Pac J Cancer Prev, 14, 6261-5.
  4. Crew KD , Neugut AI (2006). Epidemiology of gastric cancer. World J Gastroenterol, 12, 354.
  5. Evan GI, Vousden KH (2001). Proliferation, cell cycle and apoptosis in cancer. Nature, 411, 342-8.
  6. Ferlay J, Soerjomataram I, Dikshit R, et al (2014). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, 359-86.
  7. Flores ER, Tsai KY, Crowley D, et al (2002). p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature, 416, 560-4.
  8. Fu X (1991). Therapeutic effect of combined treatment with Ara-A dauricine and Chinese herbs in chronic hepatitis B infection. Zhonghua Nei Ke Za Zhi, 30, 498-501, 22.
  9. Gao XH, Yang XQ, Wang BC, et al (2013). Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer. Asian Pac J Cancer Prev, 14, 5055-60.
  10. Guggenheim DE, Shah MA (2013). Gastric cancer epidemiology and risk factors. J Surg Oncol, 107, 230-6.
  11. Guo JX, Tao QS, Lou PR, et al (2012). miR-181b as a potential molecular target for anticancer therapy of gastric neoplasms. Asian Pac J Cancer Prev, 13, 2263-7.
  12. He L, Liu GQ (2002). Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier. Acta Pharmacologica Sinica, 23, 423-9.
  13. Hiyama T, Haruma K, Kitadai Y, et al (2002). K-ras mutation in helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer. Int J Cancer, 97, 562-6.
  14. Jia-Qing Q (2002). Cardiovascular pharmacological effects of bisbenzylisoquinoline alkaloid derivatives. Acta Pharmacol Sin, 23, 1086-92.
  15. Jin H, Shen S, Chen X, et al (2012). CYP3A-mediated apoptosis of dauricine in cultured human bronchial epithelial cells and in lungs of CD-1 mice. Toxicol Appl Pharmacol, 261, 248-54.
  16. Jing C, Huang ZJ, Duan YQ, et al (2012). Glulathione-S-transferases gene polymorphism in prediction of gastric cancer risk by smoking and helicobacter pylori infection status. Asian Pac J Cancer Prev, 13, 3325-8.
  17. Johnson L, Mercer K, Greenbaum D, et al (2001). Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature, 410, 1111-6.
  18. Karapetis CS, Khambata-Ford S, Jonker DJ, et al (2008). K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med, 359, 1757-65.
  19. Kweon SS, Shu XO, Xiang Y, et al (2013). Intake of specific nonfermented soy foods may be inversely associated with risk of distal gastric cancer in a Chinese population. J Nutr, 143, 1736-42.
  20. Li WQ, Ma JL, Zhang L, et al (2014). Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. J Natl Cancer Inst, 106.
  21. Livak KJ , Schmittgen TD (2001). Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2< sup>. ${\Delta}{\Delta}$ CT Method. Methods, 25, 402-8.
  22. Meng FM, Yang JB, Yang CH, et al (2012). Vitexicarpin induces apoptosis in human prostate carcinoma PC-3 cells through G2/M Phase Arrest. Asian Pac J Cancer Prev, 13, 6369-74.
  23. Miyashita T, Krajewski S, Krajewska M, et al (1994). Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9, 1799-805.
  24. Okumura T, Ericksen RE, Takaishi S, et al (2010). K-ras mutation targeted to gastric tissue progenitor cells results in chronic inflammation, an altered microenvironment, and progression to intraepithelial neoplasia. Cancer Res, 70, 8435-45.
  25. Pellegata N, Sessa F, Renault B, et al (1994). K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res, 54, 1556-60.
  26. Shan BE, Ren FZ, Liang WJ, et al (2006). Isolation and purification of antitumor component in Rhizoma Menispermi and analysis of its activity. Teratogen Carcin Mut, 3, 7.
  27. Su YM, Zhang C, Xiao JY, et al (2007). Effects of PAMD on the proliferation human tumour cells of PC-3 and BT5637. J Harbin Medical University, 2, 14.
  28. Van Grieken NC, Aoyama T, Chambers PA, et al (2013). KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: results from a large international multicentre study. Br J Cancer, 108, 1495-501.
  29. Wang J, Li Y, Zu XB, et al (2012). Dauricine can inhibit the activity of proliferation of urinary tract tumor cells. Asian Pac J Cancer Prev, 5, 973-6.
  30. Wu X , Levine AJ (1994). p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA, 91, 3602-6.
  31. Yang XY, Jiang SQ, Zhang L, et al (2007). Inhibitory effect of dauricine on inflammatory process following focal cerebral ischemia/reperfusion in rats. Am J Chin Med, 35, 477-86.
  32. Yang Z, Li C, Wang X, et al (2010). Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-${\kappa}B$ signaling pathway in colon cancer cells. J Cell Physiol, 225, 266-75.
  33. Yao YL, Wu XY, Wu JH, et al (2013). Effects of microRNA-106 on proliferation of gastric cancer cell through regulating p21 and E2F5. Asian Pac J Cancer Prev, 14, 2839-43.
  34. Zhu CY, Lv YP, Yan DF , Gao FL (2013). Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells. Asian Pac J Cancer Prev, 14, 6757-60.
  35. Zou X, Liu SL, Zhou JY, et al (2012). Beta-asarone induces lovo colon cancer cell apoptosis by up-regulation of caspases through a mitochondrial pathway in vitro and in vivo. Asian Pac J Cancer Prev, 13, 5291-8.